Neurology Ionis Young Investigator Grant (YIG)
The Neurology Ionis Young Investigator Grant funds early-career researchers advancing innovative research on Angelman Syndrome, supported by Ionis Pharmaceuticals.
Funder: Ionis Pharmaceuticals
Due Dates (Anticipated): May 2027 (Application deadline, projected)
Funding Amounts: $50,000 per year for up to 2 years; 2 awards annually
Summary: Supports early-career researchers advancing innovative translational, clinical, or applied research on Angelman Syndrome.
Key Information: Forecasted: All dates are projected—check the program page for updates.
Description
The Neurology Ionis Young Investigator Grant (YIG) is designed to foster the development of early-career researchers conducting high-quality, innovative research in Angelman Syndrome. Administered by Ionis Pharmaceuticals, this grant aims to advance scientific understanding, improve early diagnosis, and enhance patient care for Angelman Syndrome. The program supports translational, clinical, or applied research, encouraging the next generation of leaders in neurology and rare disease research. Awards are made through a competitive review process and provide funding for up to two years.
